New hope for teens with autism and catatonia: drug and brain stimulation trial underway
NCT ID NCT07498387
First seen Mar 31, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This study tests whether benzodiazepines (a type of sedative) and electroconvulsive therapy (ECT, a controlled brain stimulation) can safely reduce catatonic symptoms—like immobility, mutism, or odd movements—in 30 adolescents aged 10-19 with profound autism. Participants receive medication or ECT over 3 months, with symptom tracking using rating scales. The goal is to ease these severe features, not cure autism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Child and Adolescent Psychiatry Clinics, Psychiatry and Neurology Center, Tanta University
Tanta, El-Gharbia Governorate, 31527, Egypt
Conditions
Explore the condition pages connected to this study.